PI3K/mTOR dual-inhibition with VS-5584 enhances anti-leukemic efficacy of ponatinib in blasts and Ph-negative LSCs of chronic myeloid leukemia-Reference-Cited by-同舟云学术

PI3K/mTOR dual-inhibition with VS-5584 enhances anti-leukemic efficacy of ponatinib in blasts and Ph-negative LSCs of chronic myeloid leukemia

Published:2021-11 Issue: Volume:910 Page:174446
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Kayabasi Cagla^ORCID,Yelken Besra Ozmen^ORCID,Asik Aycan^ORCID,Okcanoglu Tugce Balci,Sogutlu Fatma,Gasimli Roya^ORCID,Susluer Sunde Yilmaz,Saydam Guray,Avci Cigir Biray,Gunduz Cumhur

Funder

Ege Üniversitesi

Publisher

Elsevier BV

Subject

Pharmacology

Reference50 articles.

1. Characterization of ph-negative abnormal clones emerging during imatinib therapy;Abruzzese;Cancer,2007

2. Pi3k/mtor pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor;Airiau;Cell Death Dis.,2013

3. Part i: mechanisms of resistance to imatinib in chronic myeloid leukaemia;Apperley;Lancet Oncol.,2007

4. A comprehensive review on mapk: a promising therapeutic target in cancer;Braicu;Cancers,2019

5. The biology of cml blast crisis;Calabretta;Blood,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K/Akt/mTOR and dipeptidylpeptidase Ⅳ (CD26);Heliyon;2023-11

2. Anti-Cancer Role of Dendrosomal Nano Solanine in Chronic Myelogenous Leukemia Cell Line through Attenuation of PI3K/AKT/mTOR Signaling Pathway and Inhibition of hTERT Expression;Current Molecular Pharmacology;2023-08

3. The lncRNA expression profile signature of leukemia stem cells is altered upon PI3K/mTOR inhibition: an in vitro and in silico study;Nucleosides, Nucleotides & Nucleic Acids;2023-07-20

4. The effects of PKI-402 on breast tumor models’ radiosensitivity via dual inhibition of PI3K/mTOR;International Journal of Radiation Biology;2023-07-12

5. Characterization of Bone Marrow Niche in Chronic Myeloid Leukemia Patients Identifies CXCL14 as a New Therapeutic Option;Blood;2023-04-05